Topical agents in the treatment of cluster headache.
This article discusses topical intranasal medications in the treatment of cluster headache.
Markley
Herbert G
HG
New England Regional Headache Center, 85 Prescott Street, Worcester, MA 01605, USA. hmarkley@pol.net
D000281:Administration, Intranasal; D000287:Administration, Topical; D002211:Capsaicin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003027:Cluster Headache / Q000188:drug therapy*; D003042:Cocaine / Q000008:administration & dosage / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D018170:Sumatriptan / Q000008:administration & dosage / Q000627:therapeutic use; D014363:Tryptamines; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use
D023303:Oxazolidinones; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D014662:Vasoconstrictor Agents; C117479:zucapsaicin; C089750:zolmitriptan; D004087:Dihydroergotamine; D018170:Sumatriptan; D008012:Lidocaine; D003042:Cocaine; D002211:Capsaicin